Metformin - PubMed (original) (raw)

Review

Metformin

C J Bailey et al. N Engl J Med. 1996.

No abstract available

PubMed Disclaimer

Comment in

• Metformin-induced hemolysis with jaundice.
  Lin KD, Lin JD, Juang JH. Lin KD, et al. N Engl J Med. 1998 Dec 17;339(25):1860-1. doi: 10.1056/NEJM199812173392517. N Engl J Med. 1998. PMID: 9867572 No abstract available.

Similar articles

• Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
  Goo AK, Carson DS, Bjelajac A. Goo AK, et al. J Fam Pract. 1996 Jun;42(6):612-8. J Fam Pract. 1996. PMID: 8656173 Review.
• Follow-up of intensive glucose control in type 2 diabetes.
  Petrie JR. Petrie JR. N Engl J Med. 2009 Jan 22;360(4):416-7; author reply 418. N Engl J Med. 2009. PMID: 19172672 No abstract available.
• Follow-up of intensive glucose control in type 2 diabetes.
  Mühlhauser I. Mühlhauser I. N Engl J Med. 2009 Jan 22;360(4):417; author reply 418. N Engl J Med. 2009. PMID: 19172674 No abstract available.
• Thiazolidinedione derivatives in type 2 diabetes mellitus.
  Tack CJ, Smits P. Tack CJ, et al. Neth J Med. 2006 Jun;64(6):166-74. Neth J Med. 2006. PMID: 16788214 Review.
• Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
  Almirall J, Bricullé M, Gonzalez-Clemente JM. Almirall J, et al. Nephrol Dial Transplant. 2008 Jul;23(7):2436-8. doi: 10.1093/ndt/gfn152. Epub 2008 Apr 3. Nephrol Dial Transplant. 2008. PMID: 18388117 No abstract available.

Cited by

• Metformin: an old but still the best treatment for type 2 diabetes.
  Rojas LB, Gomes MB. Rojas LB, et al. Diabetol Metab Syndr. 2013 Feb 15;5(1):6. doi: 10.1186/1758-5996-5-6. Diabetol Metab Syndr. 2013. PMID: 23415113 Free PMC article.
• Metformin induces degradation of mTOR protein in breast cancer cells.
  Alalem M, Ray A, Ray BK. Alalem M, et al. Cancer Med. 2016 Nov;5(11):3194-3204. doi: 10.1002/cam4.896. Epub 2016 Oct 17. Cancer Med. 2016. PMID: 27748082 Free PMC article.
• Adsorption of drugs on B12N12 and Al12N12 nanocages.
  Geetha Sadasivan Nair R, Narayanan Nair AK, Sun S. Geetha Sadasivan Nair R, et al. RSC Adv. 2024 Oct 8;14(43):31756-31767. doi: 10.1039/d4ra05586a. eCollection 2024 Oct 1. RSC Adv. 2024. PMID: 39380648 Free PMC article.
• Anabolic and anticatabolic agents in critical care.
  Stanojcic M, Finnerty CC, Jeschke MG. Stanojcic M, et al. Curr Opin Crit Care. 2016 Aug;22(4):325-31. doi: 10.1097/MCC.0000000000000330. Curr Opin Crit Care. 2016. PMID: 27272101 Free PMC article. Review.
• Comparison of SGLT1, SGLT2, and Dual Inhibitor biological activity in treating Type 2 Diabetes Mellitus.
  Azizogli AR, Vitti MR, Mishra R, Osorno L, Heffernan C, Kumar VA. Azizogli AR, et al. Adv Ther (Weinh). 2023 Dec;6(12):2300143. doi: 10.1002/adtp.202300143. Epub 2023 Sep 17. Adv Ther (Weinh). 2023. PMID: 38223846 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information